It was reported that on (b)(6) 2019, the patient presented to the facility for an unknown reason.The patient's urine was tested on the fisher sure-vue hcg urine cassette and produced a negative result.The patient was sent for a ct scan.The customer then noticed a faint line on the test cartridge after the ct scan was performed.It is unknown how much time had passed since the patient had been tested.The customer repeated the test and another negative result was obtained.A serum sample was then collected and sent for confirmatory testing on the same day and produced a beta quant=265 miu/ml.No further information was available.Troubleshooting was conducted with the customer.Technical services discussed with the customer possible causes for unexpected results, focusing on proper sampling technique and storage conditions per the package insert.
|
The lot number of the affected product could not be provided.Therefore, all retained final-product lots within the expiration date of the date of occurrence were evaluated.Devices from these lots were tested with quality control cut-off (25miu/ml) and middle positive standard (100miu/ml).All devices were read at 3 minutes and yielded expected positive results.Manufacturing batch records of the final-product, relevant product components, and quality control release data for each of these lots were reviewed.No relevant non-conformance's, deviations, or abnormalities were found.All quality control specifications were met.All retention products performed as expected during in-house testing and could not replicate the reported complaint.Complaints are tracked and trended on a monthly basis.Case details did not indicate if the urine sample was a first morning catch.Per the package insert, very dilute urine may not contain representative levels of hcg.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
|